These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35498738)

  • 1. Dose Escalation Trial of Desulfated Heparin (ODSH) in Septic Peritonitis.
    Mauro KD; Lambert MP; Kowalska MA; Thawley VJ; Poncz M; Otto CM
    Front Vet Sci; 2022; 9():862308. PubMed ID: 35498738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Titrimetric method for determination of O-desulfated heparin in physiological samples using protamine-sensitive membrane electrode as endpoint detector.
    Buchanan SA; Kennedy TP; MacArthur RB; Meyerhoff ME
    Anal Biochem; 2005 Nov; 346(2):241-5. PubMed ID: 16213460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-O, 3-O desulfated heparin mitigates murine chemotherapy- and radiation-induced thrombocytopenia.
    Tkaczynski E; Arulselvan A; Tkaczynski J; Avery S; Xiao L; Torok-Storb B; Abrams K; Rao NV; Johnson G; Kennedy TP; Poncz M; Lambert MP
    Blood Adv; 2018 Apr; 2(7):754-761. PubMed ID: 29599195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of PF4/H multimolecular complex formation with a minimally anticoagulant heparin (ODSH).
    Joglekar MV; Quintana Diez PM; Marcus S; Qi R; Espinasse B; Wiesner MR; Pempe E; Liu J; Monroe DM; Arepally GM
    Thromb Haemost; 2012 Apr; 107(4):717-25. PubMed ID: 22318669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partially desulfated heparin modulates the interaction between anti-protamine/heparin antibodies and platelets.
    Jouni R; Zöllner H; Khadour A; Wesche J; Grotevendt A; Brandt S; Delcea M; Krauel K; Schwertz H; Sachs UJ; Greinacher A; Bakchoul T
    Thromb Haemost; 2016 Jan; 115(2):324-32. PubMed ID: 26423467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
    Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparins with reduced anti-coagulant activity reduce myocardial reperfusion injury.
    Barry WH; Kennedy TP
    Recent Pat Cardiovasc Drug Discov; 2011 May; 6(2):148-57. PubMed ID: 21453252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining prognosis in canine sepsis by bedside measurement of cell-free DNA and nucleosomes.
    Letendre JA; Goggs R
    J Vet Emerg Crit Care (San Antonio); 2018 Nov; 28(6):503-511. PubMed ID: 30299568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial.
    Busani S; Tosi M; Mighali P; Vandelli P; D'Amico R; Marietta M; Forfori F; Donati A; Cinnella G; De Monte A; Pasero D; Bellani G; Tascini C; Foti G; Ranieri M; Girardis M
    Trials; 2020 Aug; 21(1):724. PubMed ID: 32807241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study evaluating the prognostic utility of platelet indices in dogs with septic peritonitis.
    Llewellyn EA; Todd JM; Sharkey LC; Rendahl A
    J Vet Emerg Crit Care (San Antonio); 2017 Sep; 27(5):569-578. PubMed ID: 28749085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of canine-specific albumin in dogs with septic peritonitis.
    Craft EM; Powell LL
    J Vet Emerg Crit Care (San Antonio); 2012 Dec; 22(6):631-9. PubMed ID: 23216837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in critically ill dogs.
    Dourmashkin LH; Lyons B; Hess RS; Walsh K; Silverstein DC
    J Vet Emerg Crit Care (San Antonio); 2023 Jan; 33(1):52-58. PubMed ID: 36573635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-desulfated heparin improves outcome after rat cerebral ischemia/reperfusion injury.
    Mocco J; Shelton CE; Sergot P; Ducruet AF; Komotar RJ; Otten ML; Sosunov SA; Macarthur RB; Kennedy TP; Connolly ES
    Neurosurgery; 2007 Dec; 61(6):1297-303; discussion 1303-4. PubMed ID: 18162910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage function.
    Wang M; Gauthier AG; Kennedy TP; Wang H; Velagapudi UK; Talele TT; Lin M; Wu J; Daley L; Yang X; Patel V; Mun SS; Ashby CR; Mantell LL
    Mol Med; 2021 Jul; 27(1):79. PubMed ID: 34271850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of peritoneal lavage on bacterial isolates in 40 dogs with confirmed septic peritonitis.
    Marshall H; Sinnott-Stutzman V; Ewing P; Bracker K; Kalis R; Khorzad R
    J Vet Emerg Crit Care (San Antonio); 2019 Nov; 29(6):635-642. PubMed ID: 31637851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of risk factors for recurrent secondary septic peritonitis following initial surgical treatment of secondary septic peritonitis in dogs.
    Fink O; Buysse A; Drobatz KJ; Bentley A
    J Vet Emerg Crit Care (San Antonio); 2020 Mar; 30(2):213-220. PubMed ID: 32096303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Serum Apolipoprotein A1 in Canine Sepsis.
    Giunti M; Grossi G; Troía R; Fracassi F; Dondi F
    Front Vet Sci; 2020; 7():263. PubMed ID: 32478112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.
    Rao NV; Argyle B; Xu X; Reynolds PR; Walenga JM; Prechel M; Prestwich GD; MacArthur RB; Walters BB; Hoidal JR; Kennedy TP
    Am J Physiol Cell Physiol; 2010 Jul; 299(1):C97-110. PubMed ID: 20375277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies.
    Krauel K; Hackbarth C; Fürll B; Greinacher A
    Blood; 2012 Feb; 119(5):1248-55. PubMed ID: 22049520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum alpha
    Heilmann RM; Grützner N; Thames BE; Steiner JM; Barr JW
    J Vet Emerg Crit Care (San Antonio); 2017 Nov; 27(6):674-683. PubMed ID: 29068553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.